story of the week
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
Lancet Oncol 2023 Sep 11;[EPub Ahead of Print], SL Aronson, M Lopez-Yurda, SN Koole, JH Schagen van Leeuwen, HWR Schreuder, RHM Hermans, IHJT de Hingh, MDJM van Gent, HJG Arts, MAPC van Ham, PA van Dam, P Vuylsteke, AGJ Aalbers, VJ Verwaal, KK Van de Vijver, NK Aaronson, GS Sonke, WJ van DrielFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.